1
|
Hawash M, Jaradat N, Bawwab N, Salem K, Arafat H, Hajyousef Y, Shtayeh T, Sobuh S. Design, synthesis, and biological evaluation of phenyl-isoxazole-carboxamide derivatives as anticancer agents. HETEROCYCL COMMUN 2021. [DOI: 10.1515/hc-2020-0134] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022] Open
Abstract
Abstract
The present study aimed to design and synthesize a series of phenyl-isoxazole-carboxamide derivatives and investigate their antitumor and antioxidant activities. The in vitro cytotoxic evaluation was conducted using the MTS assay against four cancer cell lines: hepatocellular carcinoma (Hep3B and HepG2), cervical adenocarcinoma (HeLa), breast carcinoma (MCF-7), in addition to the normal cell line (Hek293T). Besides, the antioxidant activity was evaluated using a 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay. All obtained compounds were found to have potent to moderate activities against Hep3B and MCF-7 cancer cells lines, except compound 2e. It was found that compound 2a has potent activity against HeLa and Hep3B cancer cell lines with IC50 values of 0.91 and 8.02 µM, respectively. The IC50 dose range of the tested compounds against Hep3B was 5.96–28.62 µM, except for 2e, compared with doxorubicin, which has an IC50 value of 2.23 µM. Also, the IC50 value range of the compounds against Hek293T was 112.78–266.66 µM, compared with doxorubicin, which has an IC50 dose of 0.581 µM. The antioxidant activity of the synthesized compounds was weak, and compound 2d showed moderate activity against the DPPH enzyme with an IC50 value of 138.50 µM in comparison with Trolox, which has an IC50 dose of 37.23 µM.
Collapse
Affiliation(s)
- Mohammed Hawash
- Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University , Nablus P.O. Box 7, 00970 , Palestine
| | - Nidal Jaradat
- Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University , Nablus P.O. Box 7, 00970 , Palestine
| | - Noor Bawwab
- Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University , Nablus P.O. Box 7, 00970 , Palestine
| | - Kamilah Salem
- Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University , Nablus P.O. Box 7, 00970 , Palestine
| | - Hadeel Arafat
- Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University , Nablus P.O. Box 7, 00970 , Palestine
| | - Yousef Hajyousef
- Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University , Nablus P.O. Box 7, 00970 , Palestine
- Department of Pharmacy, Faculty of Pharmacy, Cyprus International University , Lefkosa, TRNC, Via Mersin 10, 99258 , Turkey
| | - Tahrir Shtayeh
- Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University , Nablus P.O. Box 7, 00970 , Palestine
| | - Shorooq Sobuh
- Department of Biomedical Sciences, Physiology, Pharmacology & Toxicology Division, Faculty of Medicine and Health Sciences, An-Najah National University , Nablus , Palestine
| |
Collapse
|